Howard Schwartz structures and negotiates mergers and acquisitions, complex collaborations, joint ventures, and financings for clients ranging from multinational bio-pharmaceutical and device companies to start-up biotechs. Additionally, he advises boards of directors and significant shareholders on disclosure issues, corporate communications policies, and fiduciary duty matters. His clients and deal experience extend throughout the United States, Europe and Asia as well to emerging markets and include all segments of the industry – pharma, biotech, medtech, diagnostics, animal health, vaccines and health services.
In addition, Howard regularly represents life sciences companies in their operational matters, such as global supply, distribution, clinical trials, manufacturing, and research and license arrangements between industry and academic institutions.
For over 20 years, Howard’s practice has focused on meeting the specialized corporate, commercial, and transactional needs of the life sciences industry. He is a former co-chair of our Life Sciences practice group and is recognized as a leading practitioner in his field by his peers, including in the 2016 edition of The Best Lawyers in America for the practice area of Biotechnology.
